Bionano Genomics Files Definitive Proxy Statement

Ticker: BNGO · Form: DEF 14A · Filed: Aug 21, 2024 · CIK: 1411690

Bionano Genomics, Inc. DEF 14A Filing Summary
FieldDetail
CompanyBionano Genomics, Inc. (BNGO)
Form TypeDEF 14A
Filed DateAug 21, 2024
Risk Levellow
Pages16
Reading Time20 min
Key Dollar Amounts$20,000, $20 million
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, annual-meeting, governance

Related Tickers: BNGO

TL;DR

BNGO proxy filed - vote on directors & auditors soon.

AI Summary

Bionano Genomics, Inc. filed its definitive proxy statement (DEF 14A) on August 21, 2024, for its annual meeting of stockholders. The filing outlines the proposals to be voted on, including the election of directors and the ratification of the appointment of its independent registered public accounting firm. The company is seeking shareholder approval for key corporate governance matters.

Why It Matters

This filing is crucial for shareholders as it details the agenda for the annual meeting, including director elections and auditor ratification, allowing them to make informed voting decisions.

Risk Assessment

Risk Level: low — A DEF 14A filing is a routine disclosure document for annual shareholder meetings and does not inherently present new financial risks.

Key Players & Entities

  • Bionano Genomics, Inc. (company) — Registrant
  • August 21, 2024 (date) — Filing Date
  • DEF 14A (document) — Filing Type

FAQ

What is the purpose of a DEF 14A filing?

A DEF 14A filing, or Definitive Proxy Statement, is filed by a company to solicit proxies from its shareholders for an upcoming annual or special meeting. It provides detailed information about the matters to be voted on, such as the election of directors, executive compensation, and ratification of auditors.

When was this DEF 14A filing submitted by Bionano Genomics, Inc.?

Bionano Genomics, Inc. filed this DEF 14A on August 21, 2024.

What are the typical items included in a Bionano Genomics DEF 14A filing?

Typical items include proposals for the election of directors, ratification of the appointment of the independent registered public accounting firm, and other corporate governance matters that require shareholder approval.

Who is the filer of this proxy statement?

The filer of this proxy statement is Bionano Genomics, Inc., the Registrant.

What is the fiscal year end for Bionano Genomics, Inc.?

The fiscal year end for Bionano Genomics, Inc. is December 31.

Filing Stats: 4,887 words · 20 min read · ~16 pages · Grade level 12 · Accepted 2024-08-21 16:59:15

Key Financial Figures

  • $20,000 — ments, which are not expected to exceed $20,000 in total. If you have any questions reg
  • $20 million — ds of up to an additional approximately $20 million. For additional information, please see

Filing Documents

From the Filing

DEF 14A 1 ny20032632x2_def14a.htm DEF14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material under 240.14a-12 Bionano Genomics, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): ☒ No fee required ☐ Fee paid previously with preliminary materials ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 TABLE OF CONTENTS BIONANO GENOMICS, INC. 9540 Towne Centre Drive, Suite 100 San Diego, CA 92121 NOTICE OF SPECIAL MEETING OF STOCKHOLDERS To Be Held On Wednesday, October 2, 2024 Dear Stockholders: You are cordially invited to attend a Special Meeting of Stockholders (the "Special Meeting") of Bionano Genomics, Inc., a Delaware corporation (the "Company"), to be held on Wednesday, October 2, 2024, at 10:00 a.m. Pacific Time. The Special Meeting will be held in a virtual meeting format only, via live audio webcast. You will not be able to attend the Special Meeting in person. You will be able to attend and participate in the Special Meeting online by visiting https://www.virtualshareholdermeeting.com/BNGO2024SM, where you will be able to listen to the meeting live, submit questions and vote. You will need to have the control number included in the Notice of Internet Availability of Proxy Materials (the "Notice"), on your voting instruction form, on your proxy card or on the instructions that accompanied your proxy materials to participate in the virtual Special Meeting. As always, we encourage you to vote your shares prior to the Special Meeting. You are being asked to vote on the following matter: 1. To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of up to an aggregate of 35,026,272 shares of common stock upon the exercise of certain Series A warrants and Series B warrants issued in connection with a private placement pursuant to the securities purchase agreement dated July 4, 2024, between the Company and certain institutional investors thereto. This item of business is more fully described in the Proxy Statement accompanying this notice. The record date for the Special Meeting is Monday, August 12, 2024. Only stockholders of record at the close of business on that date may vote at the Special Meeting or any adjournment thereof. Stockholders of record must have the control number included in your Notice, on your voting instruction form, on your proxy card or on the instructions that accompanied your proxy materials to participate in the Special Meeting. If your shares are held in street name and your voting instruction form or Notice indicates that you may vote those shares through the www.proxyvote.com website, then you may access, participate in, and vote at the Special Meeting with the control number indicated in your Notice, on your voting instruction form, on your proxy card or on the instructions that accompanied your proxy materials. Otherwise, stockholders who hold their shares in street name should contact their bank, broker, or other nominee (preferably at least five days before the Special Meeting) and obtain a "legal proxy" in order to be able to participate in or vote at the Special Meeting. Important Notice Regarding the Availability of Proxy Materials for the Special Meeting to Be Held on Wednesday, October 2, 2024 at 10:00 a.m. Pacific Time via live audio webcast at https://www.virtualshareholdermeeting.com/BNGO2024SM. The Company's Notice and proxy materials are available at www.proxyvote.com. By Order of the Board of Directors /s/ Jonathan Dixon Jonathan Dixon Secretary San Diego, California August 21, 2024 TABLE OF CONTENTS You are cordially invited to attend the virtual Special Meeting. Whether or not you expect to attend the Special Meeting, PLEASE VOTE YOUR SHARES. As an alternative to voting online at the Special Meeting, you may vote via the internet, by telephone or, if you receive a paper proxy card, by mailing the completed proxy card as promptly as possible in order to ensure your representation at the Special Meeting. Voting instructions are provided in the Notice of Internet Availability of Proxy Materials, or, if you receive a paper proxy card by mail, the instructions are printed on your proxy card. Even if you have voted by proxy, you may still vote online at the Special Meeting. Please note, however

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.